322 Efficacy and safety of GX-I7 plus pembrolizumab for heavily pretreated patients with metastatic triple negative breast cancer: The Phase 1b/2 KEYNOTE-899 Study

• Joo Sohn,
• Young Hyuk Im

Affiliations

Joo Sohn

1Severance Hospital, Seoul, Korea, Republic of

Young Hyuk Im

2Samsung Medical Center, Seoul, Korea, Republic of